Connect with us

General

India expects lion’s share of surplus US AstraZeneca vaccines as COVID-19 cases mount

Published

on


India expects to secure the biggest chunk of the 60 million AstraZeneca COVID-19 vaccine doses that the United States will share globally, two Indian government sources said as New Delhi battles a devastating surge in infections.

On Monday, the White House said 10 million doses could be cleared for export “in coming weeks” and the rest…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending